The 'supervirus'? Lessons from IL-4-expressing poxviruses

Trends in Immunology

Volumn 26, Issue 6, 2005, Pages 339-345

  Stanford, Marianne M ^a   McFadden, Grant ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

CELLULAR IMMUNITY; ECTROMELIA VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MYXOMA VIRUS; NONHUMAN; PATHOGENICITY; POXVIRUS; PROTEIN EXPRESSION; REVIEW; SMALLPOX; TH1 CELL; TH2 CELL; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS VIRULENCE;

ANIMALS; BIOTERRORISM; HUMANS; INTERLEUKIN-4; POXVIRIDAE; POXVIRIDAE INFECTIONS; T-LYMPHOCYTES, HELPER-INDUCER; VIRULENCE;

EID: 19544365712     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.04.001     Document Type: Review

References (55)

1. R.B. Moss Th1/Th2 cells in inflammatory disease states: therapeutic implications Expert Opin. Biol. Ther. 4 2004 1887 1896
2. A. Bot Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology DNA Cell Biol. 23 2004 341 350
3. T.R. Mosmann, and S. Sad The expanding universe of T-cell subsets: Th1, Th2 and more Immunol. Today 17 1996 138 146
4. + T cells Ciba Found. Symp. 195 1995 42 50
5. G. Karupiah Type 1 and type 2 cytokines in antiviral defense Vet. Immunol. Immunopathol. 63 1998 105 109
6. P. Kidd Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease Altern. Med. Rev. 8 2003 223 246
7. S. Romagnani Th1 and Th2 in human diseases Clin. Immunol. Immunopathol. 80 1996 225 235
8. B. Spellberg, and J.E. Edwards Jr Type 1/type 2 immunity in infectious diseases Clin. Infect. Dis. 32 2001 76 102
9. B.T. Seet Poxviruses and immune evasion Annu. Rev. Immunol. 21 2003 377 423
10. J.B. Johnston, and G. McFadden Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes Cell. Microbiol. 6 2004 695 705
11. R.M. Buller, and G.J. Palumbo Poxvirus pathogenesis Microbiol. Rev. 55 1991 80 122
12. A.J. Ramsay A case for cytokines as effector molecules in the resolution of virus infection Immunol. Today 14 1993 155 157
13. - cells that make TH2 cytokines and help B cells Science 260 1993 1802 1805
14. S. Benedetti Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene Cancer Res. 59 1999 645 652
15. S. Andreansky Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins Gene Ther. 5 1998 121 130
16. H. Ghiasi Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in mice J. Virol. 75 2001 9029 9036
17. M. Fernandez Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease J. Virol. 76 2002 895 904
18. G. McFadden Poxvirus tropism Nat. Rev. Microbiol. 3 2005 201 213
19. I.A. Ramshaw Cytokines and immunity to viral infections Immunol. Rev. 159 1997 119 135
20. B. Moss Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety Proc. Natl. Acad. Sci. U. S. A. 93 1996 11341 11348
21. Z.S. Guo, and D.L. Bartlett Vaccinia as a vector for gene delivery Expert Opin. Biol. Ther. 4 2004 901 917
22. M.J. Mastrangelo, and E.C. Lattime Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors Cancer Gene Ther. 9 2002 1013 1021
23. M.E. Andrew, and B.E. Coupar Biological effects of recombinant vaccinia virus-expressed interleukin 4 Cytokine 4 1992 281 286
24. D.P. Sharma Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo J. Virol. 70 1996 7103 7107
25. G.P. Bembridge Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or γ interferon J. Virol. 72 1998 4080 4087
26. + respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo J. Virol. 73 1999 8944 8949
27. S. Aung, and B.S. Graham IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity in vivo J. Immunol. 164 2000 3487 3493
28. + T cells Microbes Infect. 5 2003 923 932
29. N. Chen The genomic sequence of ectromelia virus, the causative agent of mousepox Virology 317 2003 165 186
30. A. Mullbacher Cell-mediated cytotoxicity in recovery from poxvirus infections Rev. Med. Virol. 13 2003 223 232
31. G. Chaudhri Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox Proc. Natl. Acad. Sci. U. S. A. 101 2004 9057 9062
32. R.J. Jackson Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox J. Virol. 75 2001 1205 1210
33. E. Finkel Australia. Engineered mouse virus spurs bioweapon fears Science 291 2001 585
34. R.J. Jackson Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3 Biol. Reprod. 58 1998 152 159
35. S.J. Robbins The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4 Antiviral Res. 66 2005 1 7
36. C. Cheers Use of recombinant viruses to deliver cytokines influencing the course of experimental bacterial infection Immunol. Cell Biol. 77 1999 324 330
37. M.N. Norazmi Possible mechanism for the enhanced lethality of an interleukin-4-expressing mousepox virus J. Med. Microbiol. 50 2001 936
38. G. Karupiah Importance of interferons in recovery from mousepox J. Virol. 67 1993 4214 4226
39. A. Mullbacher, and M. Lobigs Creation of killer poxvirus could have been predicted J. Virol. 75 2001 8353 8355
40. L.H. McCurdy Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4 J. Virol. 78 2004 12471 12479
41. F. Fenner, and F.N. Ratcliffe Myxomatosis 1965 Cambridge University Press
42. P. Kerr, and G. McFadden Immune responses to myxoma virus Viral Immunol. 15 2002 229 246
43. P.J. Kerr, and S.M. Best Myxoma virus in rabbits Rev. Sci. Tech. 17 1998 256 268
44. P.J. Kerr Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis Virology 324 2004 117 128
45. Y. Becker Vaccinia virus pathogenicity in atopic dermatitis is caused by allergen-induced immune response that prevents the antiviral cellular and humoral immunity Virus Genes 27 2003 269 282
46. L.H. McCurdy Modified vaccinia Ankara: potential as an alternative smallpox vaccine Clin. Infect. Dis. 38 2004 1749 1753
47. A. Mullbacher Can we really learn from model pathogens? Trends Immunol. 25 2004 524 528
48. J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J. Immunol. 172 2004 2731 2738
49. W.P. Cheevers Immune response to caprine arthritis-encephalitis virus surface protein induced by coimmunization with recombinant vaccinia viruses expressing the caprine arthritis-encephalitis virus envelope gene and caprine interleukin-12 Vaccine 18 2000 2494 2503
50. P.B. Jahrling Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox Proc. Natl. Acad. Sci. U. S. A. 101 2004 15196 15200
51. K.H. Rubins The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model Proc. Natl. Acad. Sci. U. S. A. 101 2004 15190 15195
52. A. Mantovani The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol. 25 2004 677 686
53. G. McFadden Smallpox: an ancient disease enters the modern era of virogenomics Proc. Natl. Acad. Sci. U. S. A. 101 2004 14994 14995
54. K.L. Elkins In vivo delivery of interleukin-4 by a recombinant vaccinia virus prevents tumor development in mice Hum. Gene Ther. 5 1994 809 820
55. T.R. Mosmann Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J. Immunol. 136 1986 2348 2357